3 insiders reported 6 Form 4 transactions for Ascendis Pharma A/S (ASND) over the past 18 months (most recent 2026-06-02). Recent activity: SMITH SCOTT THOMAS (EVP & Chief Financial Officer) Buy 100 shares, BIENAIME JEAN JACQUES (Director) Buy 200 shares, SMITH SCOTT THOMAS (EVP & Chief Financial Officer) Buy 250 shares, BIENAIME JEAN JACQUES (Director) Buy 200 shares, BIENAIME JEAN JACQUES (Director) Buy 100 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | Buy | 100 | $21,900 |
| 2026-06-01 | BIENAIME JEAN JACQUES | Director | Buy | 200 | $44,752 |
| 2026-06-01 | SMITH SCOTT THOMAS | EVP & Chief Financial Officer | Buy | 250 | $55,830 |
| 2026-06-01 | BIENAIME JEAN JACQUES | Director | Buy | 200 | $44,460 |
| 2026-06-01 | BIENAIME JEAN JACQUES | Director | Buy | 100 | $22,350 |
| 2026-05-12 | JENSEN FLEMMING STEEN | See Remarks | Sell | 19,460 | $4.6M |
Source: SEC Form 4 filings · as of 2026-06-02